Cargando…

Shape-Attributes of Brain Structures as Biomarkers for Alzheimer’s Disease

We describe a fully automatic framework for classification of two types of dementia based on the differences in the shape of brain structures. We consider Alzheimer’s disease (AD), mild cognitive impairment of individuals who converted to AD within 18 months (MCIc), and normal controls (NC). Our app...

Descripción completa

Detalles Bibliográficos
Autores principales:	Glozman, Tanya, Solomon, Justin, Pestilli, Franco, Guibas, Leonidas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240557/ https://www.ncbi.nlm.nih.gov/pubmed/27911322 http://dx.doi.org/10.3233/JAD-160900

Ejemplares similares

A single mode of population covariation associates brain networks structure and behavior and predicts individual subjects’ age
por: McPherson, Brent C., et al.
Publicado: (2021)

Multidimensional encoding of brain connectomes
por: Caiafa, Cesar F., et al.
Publicado: (2017)

Bundle analytics, a computational framework for investigating the shapes and profiles of brain pathways across populations
por: Chandio, Bramsh Qamar, et al.
Publicado: (2020)

Plasma Biomarkers of Brain Atrophy in Alzheimer's Disease
por: Thambisetty, Madhav, et al.
Publicado: (2011)

Structural Insight into RNA Hairpin Folding Intermediates
por: Bowman, Gregory R., et al.
Publicado: (2008)

Staging Alzheimer’s Disease Risk by Sequencing Brain Function and Structure, Cerebrospinal Fluid, and Cognition Biomarkers
por: Chen, Guangyu, et al.
Publicado: (2016)

Prognosis of Biomarker of Alzheimer's Disease in the Function of the Retina and Secondary Molecular Structure Variation of the Retina and Brain
por: Gaber, Heba Ahmed, et al.
Publicado: (2023)

Retinal Alterations as Potential Biomarkers of Structural Brain Changes in Alzheimer’s Disease Spectrum Patients
por: Hu, Zheqi, et al.
Publicado: (2023)

Recalled attributes of parents with Alzheimer's disease: relevance for caregiving
por: Chiriboga, David A., et al.
Publicado: (2014)

Differing effects of attention in single-units and populations are well predicted by heterogeneous tuning and the normalization model of attention
por: Hara, Yuko, et al.
Publicado: (2014)

Test-retest measurements and digital validation for in vivo neuroscience
por: Pestilli, Franco
Publicado: (2015)

Human white matter and knowledge representation
por: Pestilli, Franco
Publicado: (2018)

How Disability Stereotypes Shape Memory for Personal Attributes
por: Tempel, Tobias, et al.
Publicado: (2023)

Brain Shape Changes Associated With Cerebral Atrophy in Healthy Aging and Alzheimer’s Disease
por: Blinkouskaya, Yana, et al.
Publicado: (2021)

Temporospatial components of brain ERPs as biomarkers for Alzheimer's disease
por: Chapman, Robert M., et al.
Publicado: (2018)

3DPointCaps++: Learning 3D Representations with Capsule Networks
por: Zhao, Yongheng, et al.
Publicado: (2022)

Cognitive biomarker prioritization in Alzheimer’s Disease using brain morphometric data
por: Peng, Bo, et al.
Publicado: (2020)

Clustering of Brain Function Network Based on Attribute and Structural Information and Its Application in Brain Diseases
por: Cui, Xiaohong, et al.
Publicado: (2020)

Transferrin Biosynthesized in the Brain Is a Novel Biomarker for Alzheimer’s Disease
por: Hoshi, Kyoka, et al.
Publicado: (2021)

Structural brain imaging in Alzheimer’s disease and mild cognitive impairment: biomarker analysis and shared morphometry database
por: Ledig, Christian, et al.
Publicado: (2018)

Salivary lactoferrin as biomarker for Alzheimer's disease: Brain‐immunity interactions
por: Bermejo‐Pareja, Félix, et al.
Publicado: (2020)

Integrated transcriptomics reveals the brain and blood biomarkers in Alzheimer's disease
por: Yu, Haitao, et al.
Publicado: (2023)

Brain structure and allelic associations in Alzheimer's disease
por: Moon, Seok Woo, et al.
Publicado: (2022)

Effects of Physical Activity on Brain Energy Biomarkers in Alzheimer’s Diseases
por: Ebrahimi, Khadijeh, et al.
Publicado: (2020)

The protective impact of education on brain structure and function in Alzheimer’s disease
por: Zhu, Wanqiu, et al.
Publicado: (2021)

Imaging asparaginyl endopeptidase (AEP) in the live brain as a biomarker for Alzheimer’s disease
por: Wang, Shan-Shan, et al.
Publicado: (2021)

Plasma biomarkers are associated with agitation and regional brain atrophy in Alzheimer’s disease
por: Hsu, Jung-Lung, et al.
Publicado: (2017)

Learning Disabilities in Primary School. How to Diagnose and Remediate the Difficulties with a Team Approach: The First Results
por: Glozman, Janna M., et al.
Publicado: (2019)

Longitudinal brain atrophy and CSF biomarkers in early-onset Alzheimer’s disease
por: Contador, José, et al.
Publicado: (2021)

Co-twin design in brain imaging—review on biomarkers of Alzheimer's disease
por: Varjonen, Anni, et al.
Publicado: (2023)

Disease X: accelerating the development of medical countermeasures for the next pandemic
por: Simpson, Shmona, et al.
Publicado: (2020)

Identification and validation of Alzheimer’s disease-related metabolic brain pattern in biomarker confirmed Alzheimer’s dementia patients
por: Perovnik, Matej, et al.
Publicado: (2022)

Open data on industry payments to healthcare providers reveal potential hidden costs to the public
por: Mejia, Jorge, et al.
Publicado: (2019)

The spread of COVID-19 increases with individual mobility and depends on political leaning
por: Parker, Chris, et al.
Publicado: (2021)

Cortisol, cognition and Alzheimer’s disease biomarkers among memory clinic patients
por: Holleman, Jasper, et al.
Publicado: (2022)

Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease
por: Irwin, David J., et al.
Publicado: (2020)

Functionally defined white matter of the macaque monkey brain reveals a dorso-ventral attention network
por: Sani, Ilaria, et al.
Publicado: (2019)

Biomarkers in Alzheimer’s Disease
por: Riverol, Mario, et al.
Publicado: (2011)

Biomarkers in Alzheimer’s disease
por: Janeiro, Manuel H., et al.
Publicado: (2020)

Assessment of the quality of brain regions and neuroimaging metrics as biomarkers of Alzheimer’s Disease
por: Vaz, Tânia Faria, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1vlgc2tuc329e2aqiu0tsn11c1